Orally active azole derivatives
AssigneeJ. Uriach & Cia. S.A.
InventorsJavier Bartroli, Enric Turmo, Manuel Anguita, Elena Carceller, Carmen Almansa
Life of this patent
Estimating the term…
Loading patent…
AssigneeJ. Uriach & Cia. S.A.
InventorsJavier Bartroli, Enric Turmo, Manuel Anguita, Elena Carceller, Carmen Almansa
Estimating the term…
The present invention relates to new orally active azole derivatives with antifungal activity of formula I ##STR1## wherein: X is CH or N; Ar represents phenyl substituted with halogen and/or trifluoromethyl; Z is --C(=O)-- or --SO.sub.2 --; R.sub.1 is CN, CO.sub.2 H, CO.sub.2 R.sub.7, CONR.sub.8 R.sub.9 or CH.sub.2 Y and then R.sub.3 is hydrogen, or R.sub.1 together with R.sub.3 forms a ring of formula I' ##STR2## wherein B is O, hydroxy or hydrogen; R.sub.4 is C.sub.1-4 alkyl; R.sub.5, R.sub.6, R.sub.8 and R.sub.9 are hydrogen or C.sub.1-4 alkyl; Y is --OH, --OR.sub.7, --OC(=O)R.sub.7, --NR.sub.8 R.sub.9, --NHC(=O)OR.sub.7 ; R.sub.7 is C.sub.1 -C.sub.4 -alkyl, phenyl-C.sub.1 -C.sub.4 -alkyl or optionally substituted phenyl; when Z is --C(=O)--, R.sub.2 is optionally susbtituted phenyl, or naphtyl; when Z is --SO.sub.2 --, R.sub.2 is C.sub.1-4 alkyl, phenyl-C.sub.1-4 -alkyl or optionally susbtituted phenyl.
A compound of the formula ##STR110## as a racemate, a diastereoisomer mixture or as a homochiral compound wherein:
(SR*,6R*)-6-[2,4-Difluorophenyl ]-5-methyl-4-[4-(trifluoromethyl)benzoyl]-6-[(1H-l,2,4-triazol-1-yl)methyl ]-2-morpholinone or a salt or solvate thereof.
(SR,6R)-6-[2,4-Difluorophenyl]-5-methyl-4- [4-(trifluoromethyl)benzoyl]-6-(1H-1,2,4-triazol-1-yl)methyl]-2-morpholinon e or a salt or solvate thereof.
(SR*,6R*)-6-[2,4-Dichloroph enyl]-5-methyl-4-[4-(trifluoromethyl)benzoyl]-6-[(1H-1,2,4-triazol-1-yl)met hyl]-2-morpholinone or a salt or solvate thereof.
(5R,6R)-6-[2,4-Dichlorophenyl]-5-methyl-4-[4- (trifluoromethyl)benzoyl]-6-(1H-1,2,4-triazol-1-yl)methyl]-2-morpholinone or a salt or solvate thereof.
(5R*,6R*)-6-[2,4-Difluorop henyl]-5-methyl-2-hydroxy-4-[4-(trifluoromethyl)benzoyl]-6-[(1H-1,2,4-triaz ol-1-yl)methyl]morpholine or a salt or solvate thereof.
(SR,6R)-6-[2,4-Difluorophenyl]-5-methyl-2-hydroxy-4 -[4-(trifluoromethyl)-benzoyl]-6-[(1H-1,2,4-triazol-1-yl)methyl]morpholine or a salt or solvate thereof.
(5R*,6R*)-6-[2,4-Dichlorop henyl]-5-methyl-2-hydroxy-4-[4-(trifluoromethyl)benzoyl]-6-[(1H-1,2,4-triaz ol-1-yl)methyl]morpholine or a salt or solvate thereof.
(SR,6R)-6-[2,4-Dichlorophenyl]-5-methyl-2-hydroxy-4 -[4-(trifluoromethyl)-benzoyl]-6-[(1H-1,2,4-triazol-1-yl)methyl]morpholine or a salt or solvate thereof.
(5R*,6R*)-6-[2,4-Difluorop henyl]-5-methyl-4-[2-fluoro-4-(trifluoromethyl)-benzoyl]-6-[(1H-1,2,4-triaz ol-1-yl)methyl]-2-morpholinone or a salt or solvate thereof.
(5R,6R)-6-[2,4-Difluorophenyl]-5-methyl-4-[2-fluoro-4-(t rifluoromethyl)-benzoyl]-6-[(1H-I,2,4-triazol-]-yl)methyl]-2-morpholinone or a salt or solvate thereof.
(5R*,6R*)-6-[2,4-Difluorop henyl]-5-methyl-4-[4-(trifluoromethyl)benzoyl]-6-[(1H-1,2,4-triazol-1-yl)me thyl]morpholine, or a pharmaceutically acceptable salt or solvate thereof.
(5R,6R)-6-[2,4-Difluorophenyl]-5-methyl-4-[4-(trifluoromethyl)benzoyl]6 [(1H-1,2,4-triazol-1-yl)methyl]morpholine, or a pharmaceutically acceptable salt or solvate thereof.
(5R*,6R*)-6-[2,4-Difl uorophenyl]-5-methyl-4-[4-(trifluoromethyl)benzoyl]-6-[(1H-1, 2,4-triazol-1-yl) methyl]morpholine ethanolate.
(5R,6R)-6-[2,4-Difluorophenyl]-5-methyl-4-[4 -(trifluoromethyl)benzoyl]-6-[(1H-1,2,4-triazol-1-yl) methyl]morpholine ethanolate.
(5R*,6R* )-6-[2,4-Difluorophenyl]-5-methyl-2-hydroxy-4-[4-(trifluoromethyl)benzoyl]- 6-[(1H-1, 2,4-triazol-1-yl) methyl]morpholine ethanolate.
(5R,6R)-6-[2,4-Difluorophenyl]-5-methyl-2-hydroxy-4-[ 4-(trifluoromethyl)benzoyl]-6-[(1H-1,2,4-triazol-1-yl)methyl]morpholine ethanolate.
Dependencies are inferred from the claim text.